ATE127013T1 - Aerosolzusammensetzungen. - Google Patents

Aerosolzusammensetzungen.

Info

Publication number
ATE127013T1
ATE127013T1 AT91919751T AT91919751T ATE127013T1 AT E127013 T1 ATE127013 T1 AT E127013T1 AT 91919751 T AT91919751 T AT 91919751T AT 91919751 T AT91919751 T AT 91919751T AT E127013 T1 ATE127013 T1 AT E127013T1
Authority
AT
Austria
Prior art keywords
propellant
aerosol compositions
cosolvent
medicament
surfactant
Prior art date
Application number
AT91919751T
Other languages
English (en)
Inventor
Anthony James Taylor
Patricia Kwong Phieu Burnell
Park Road Limited
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10685109&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE127013(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE127013T1 publication Critical patent/ATE127013T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT91919751T 1990-11-09 1991-11-07 Aerosolzusammensetzungen. ATE127013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909024365A GB9024365D0 (en) 1990-11-09 1990-11-09 Medicaments

Publications (1)

Publication Number Publication Date
ATE127013T1 true ATE127013T1 (de) 1995-09-15

Family

ID=10685109

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919751T ATE127013T1 (de) 1990-11-09 1991-11-07 Aerosolzusammensetzungen.

Country Status (11)

Country Link
EP (1) EP0556256B1 (de)
JP (1) JP3210012B2 (de)
AT (1) ATE127013T1 (de)
AU (1) AU660952B2 (de)
CA (1) CA2094726C (de)
DE (1) DE69112637T2 (de)
DK (1) DK0556256T3 (de)
ES (1) ES2078551T3 (de)
GB (1) GB9024365D0 (de)
GR (1) GR3018172T3 (de)
WO (1) WO1992008446A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
CA2111003A1 (en) * 1991-06-10 1992-12-23 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
DE4132176C2 (de) * 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
ATE171865T1 (de) 1991-12-12 1998-10-15 Glaxo Group Ltd Arzneimittel
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ES2099415T3 (es) * 1991-12-18 1997-05-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
KR970701535A (ko) * 1994-03-14 1997-04-12 지울리아노 페트렐리 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E)
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
EP0810853B1 (de) 1995-02-24 2004-08-25 Elan Pharma International Limited Nanopartikel-dispersionen enthaltende aerosole
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
CA2217954C (en) * 1995-04-14 2005-02-15 Glaxo Wellcome Inc. Metered dose inhaler for salmeterol
NZ306281A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
TR199701167T1 (xx) * 1995-04-14 1998-03-21 Glaxo Wellcome Inc. Albuterol i�in �l��lm�� doz inhaleri.
SK284448B6 (sk) * 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
GB9526392D0 (en) * 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
AU774250B2 (en) * 1997-06-13 2004-06-24 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CN1145478C (zh) * 1998-04-18 2004-04-14 葛兰素集团有限公司 药用气溶胶制剂
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
ATE233084T1 (de) * 1999-04-14 2003-03-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1920763E (pt) 2000-11-30 2014-06-25 Vectura Ltd Composições farmacêuticas para inalação
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations

Also Published As

Publication number Publication date
EP0556256A1 (de) 1993-08-25
JPH06501700A (ja) 1994-02-24
JP3210012B2 (ja) 2001-09-17
DK0556256T3 (da) 1995-11-06
WO1992008446A1 (en) 1992-05-29
ES2078551T3 (es) 1995-12-16
AU8877891A (en) 1992-06-11
CA2094726A1 (en) 1992-05-10
GR3018172T3 (en) 1996-02-29
CA2094726C (en) 2002-01-15
GB9024365D0 (en) 1991-01-02
AU660952B2 (en) 1995-07-13
DE69112637D1 (de) 1995-10-05
EP0556256B1 (de) 1995-08-30
DE69112637T2 (de) 1996-02-08

Similar Documents

Publication Publication Date Title
DE69112637D1 (de) Aerosolzusammensetzungen.
GEP20002140B (en) Pharmaceutical Aerosol Composition
ATE125153T1 (de) Treibmittelzubereitungen.
GR3018171T3 (en) Aerosol containing medicaments.
PT81839A (en) Drug-containing chlorofluorocarbon aerosol propellent formulation
PT918507E (pt) Formulacoes em aerossol
CA2009169A1 (en) C3 to c5 polyfluoroalkanes propellants
PT98105A (pt) Processo para a preparacao de formulacoes em aerossol contendo como propulsor 1,1,1,2-tetrafluoroetano
ES2112308T3 (es) Composiciones de glifosatos y su uso.
MX9101354A (es) Composiciones detergentes que tienen agentes tensioactivos de amida de acido graso polihidroxilico y alquil-etersulfonato
ES2086377T3 (es) Procedimiento para tratar o revestir un sustrato con una composicion acuosa y uso de dichas composiciones.
GB8514975D0 (en) Compositions
HUP9901869A2 (hu) Parfüm alkoholok béta-amino-karbonsav-észter származékai
AU4794079A (en) Surfactant compositions and pesticide formulations
JPS523023A (en) Preparation of amino acid ester of organopolysiloxane
JPS55139313A (en) Gel cream composition comprising higher fatty acid ethanol amide, and drug containing it
JPS5668616A (en) Preparation of antibiotic composition
ES8604017A1 (es) Un procedimiento para la preparacion de una formulacion desodorante de alcohol inferior aminoalcanol inferior o medio.
ATE108479T1 (de) Anethol enthaltende ethanolische zusammensetzungen.
JPS5765761A (en) Antistatic, acting ray-curable coat composition
JPS63249566A (ja) 泡沫状芳香剤エアゾ−ル組成物
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
SE9004076D0 (sv) Anvaendning av 10-acetyl-1,8,9-triacetoxi-antracen som antiinflammatoriskst medel vid framstaellning av farmaceutiska och kosmetiska kompositioner
DE3824939A1 (de) Neue 2,2-dihalogencyclopropylhydroxyethyltriazole enthaltende antimykotische mittel
CA2303709A1 (en) C3 to c5 polyfluoroalkanes propellants

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked